2021/05/05 13:00:00 水 05 5月 2021
2021/05/05 14:30:00 水 05 5月 2021
に公開 2021年 3月 23日
起こった 2021年 5月 5日
Join our panel of experts from around the world to learn about Chronic disease management in the post COVID era - the value of point of care testing for cardiovascular risk and kidney disease management in diabetes and non diabetes patients. The webinar will analyse studies and present front line experience on the value of point of care testing told through the eyes of internationally acclaimed health care professionals and academics from Germany...
に公開 2021年 4月 4日
Adoption of Point-of-Care testing services in diabetes and in the context of COVID-19
に公開 2021年 9月 9日
この特集記事では、特にポイントオブケア検査(POCT)に関連する出版物を取り上げ、論文の重要な側面やPOCTシステムの幅広い内容について、要約と専門家のコメントを掲載しています。 この記事では、El Osta博士と共著者による以下の出版物を取り上げます。 ポイントオブケア検査を使用することで、プライマリーケアにおけるNHS健康診断プログラムの費用対効果は向上するか?コスト最小化のための分析 心血管疾患は若年死の原因 心血管疾患(CVD)は、世界的に身体障害や若年死の主な原因であり、英国だけでも年間死亡者数の約3分の1を占めています。CVDの負担を軽減するために、2009年4月、英国保健省は、全国規模のCVD一次予防プログラムである国民保健サービス(NHS)健康診断プログラムを開始しました。このプログラムは、心臓病、脳卒中、糖尿病、腎臓病を予防し、健康格差を是正すること...
2021/07/22 17:00:00 木 22 7月 2021
2021/07/22 18:30:00 木 22 7月 2021
に公開 2021年 6月 10日
起こった 2021年 7月 22日
The importance of pediatric lipid testing in the diagnosis and treatment of familial hypercholesterolemia
2021/09/21 12:00:00 火 21 9月 2021
2021/09/21 13:30:00 火 21 9月 2021
に公開 2021年 8月 21日
起こった 2021年 9月 21日
Cardiovascular diseases are a leading cause of death globally, taking 17.9 million lives each year1. Patients at risk of cardiovascular disease (CVD) may show raised blood pressure, have diabetes or have high lipid levels. The good news is, reducing the risk of cardiovascular disease (such as dyslipidemia, hypercholesterolemia and hypertriglyceridemia) is possible with lipid panel tests to identify risk, and continued testing for monitoring.
2021/06/30 17:00:00 水 30 6月 2021
2021/06/30 18:00:00 水 30 6月 2021
に公開 2021年 6月 14日
起こった 2021年 6月 30日
The value of CRP point-of-care testing in the fight against antimicrobial resistance
2021/08/30 11:00:00 月 30 8月 2021
2021/08/30 12:30:00 月 30 8月 2021
に公開 2021年 10月 29日
起こった 2021年 8月 30日
Join this session to learn from experts in cardiovascular disease prevention about the recent evidence on risk stratification, to get insights from their daily clinical practice and to learn how to use cardiac biomarkers and lipid profile in a more efficient way
2022/07/20 12:00:00 水 20 7月 2022
2022/07/20 13:00:00 水 20 7月 2022
に公開 2022年 6月 23日
起こった 2022年 7月 20日
Audio em Japones
2023/10/16 15:00:00 月 16 10月 2023
2023/10/16 16:00:00 月 16 10月 2023
に公開 2023年 10月 23日
起こった 2023年 10月 16日
中国、日本、インドの医療専門家の方々のパネルディスカッションをご視聴いただけます。腎臓病を診断するための患者中心のアプローチとして、ポイントオブケア検査 (POCT) の価値について意見交換がされています。これらのプレゼンテーションは、POCT の利点や早期診断の重要性の探求から、腎疾患を効果的に管理する上での継続的なモニタリングと患者教育の重要な役割まで、幅広い情報を網羅しています。
2022/10/05 15:00:00 水 05 10月 2022
2022/10/05 19:30:00 水 05 10月 2022
に公開 2022年 8月 11日
起こった 2022年 10月 5日
2020/11/30 14:30:00 月 30 11月 2020
2020/11/30 16:00:00 月 30 11月 2020
に公開 2020年 10月 13日
起こった 2020年 11月 30日
Watch the exclusive on-demand event recording only on myPOCacademy. This video seminar features a global panel of experts including Professor Oliver Schnell (Germany), Professor Neale Cohen (Australia), Dr Erna Lenters Westra (The Netherlands), Dr Devaki Nair (UK), Dr Peter Johansson (Sweden), Dr Enrico Torre (Italy) and Professor Bernd Schultes (Switzerland). Click here to see the full programme and watch the video seminar.
2020/07/13 13:00:00 月 13 7月 2020
2020/07/13 14:00:00 月 13 7月 2020
に公開 2020年 7月 1日
起こった 2020年 7月 13日
Check out the on-demand educational recording from Africa Online Healthcare Week 2020 by clicking here. Dr Susanne Emmerich (Germany) discusses the relationship between diabetes and COVID-19, and how HbA1c point-of-care testing (POCT) impacts glycemic control in diabetic patients. Dr Carl Llor (Spain) discusses the value of C-reactive protein (CRP) POCT to aid assessment of COVID-19 and prevent unnecessary prescription of antibiotics.
2020/09/07 7:15:00 月 07 9月 2020
2020/09/07 8:15:00 月 07 9月 2020
に公開 2020年 9月 1日
起こった 2020年 9月 7日
Check out the on-demand symposium recording from the European Respiratory Society congress 2020 by clicking here. Learn how C-reactive protein (CRP) point-of-care testing can be a valuable diagnostic and clinical decision-making tool in relation to COVID-19, and how it may also inform antibiotic prescribing for acutely exacerbated chronic obstructive pulmonary disease (COPD) patients.
2020/09/04 18:30:00 金 04 9月 2020
2020/09/04 19:45:00 金 04 9月 2020
に公開 2020年 7月 28日
起こった 2020年 9月 4日
An international expert panel discusses POCT related to COVID-19 severity assessment and risk prediction, plus covers the role of POCT in antimicrobial resistance during the pandemic, in this video seminar originally delivered live on 9 September 2020. Hear from Professor Nicholas Francis (UK), Professor Ivan Gentile (Italy), Dr Carl Llor (Spain), Professor Dag Berild (Norway) and Dr Aggy York (UK) by clicking here.
に公開 2020年 9月 5日
An international expert panel discusses POCT related to COVID-19 severity assessment and risk prediction, plus covers the role of POCT in antimicrobial resistance during the pandemic, in this video seminar originally delivered live on 4 September 2020. Hear from Professor Nicholas Francis (UK), Professor Ivan Gentile (Italy), Dr Carl Llor (Spain), Professor Dag Berild (Norway) and Dr Aggy York (UK) by clicking here.
2020/10/09 3:00:00 金 09 10月 2020
に公開 2020年 10月 1日
起こった 2020年 10月 9日
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with ~800 attendees from across ~50 countries and more than 250 speakers. This year, on 8–9 October 2020, myPOCacademy hosted a live seminar led by Professor Jonathan Cooke from Imperial College London and the University of Manchester (UK), now exclusively available to watch in full here.
に公開 2020年 7月 18日
に公開 2020年 9月 10日
The ERS international congress on 7–9 September 2020 delivered the latest innovations in respiratory medicine, plus offered an opportunity to interact and connect with the respiratory community virtually.
に公開 2020年 10月 5日
The American Diabetes Association (ADA) recommends that HbA1c tests should be performed using a method that is certified by NGSP.
に公開 2020年 9月 26日
The EASD virtual annual congress 2020 took place on 21–25 September with more than 20,000 delegates in attendance.
に公開 2020年 10月 10日
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with approximately 800 attendees from across approximately 50 countries and more than 250 speakers.
に公開 2020年 9月 2日
The ESC digital congress (29 August to 1 September 2020) was attended by approximately 125,000 healthcare professionals from across 213 countries.
に公開 2021年 1月 18日
Listen to our latest expert podcast discussing respiratory tract infections in the context of COVID-19
2021/06/04 15:00:00 金 04 6月 2021
に公開 2021年 6月 22日
起こった 2021年 6月 4日
HbA1c and CRP point-of-care testing as important tools in managing patients with diabetes and patients with COVID-19
Africa Healthcare Week Online is the largest ever virtual event for African healthcare. It features thousands of attendees, with over 80 webinar speakers, including panel discussions and case studies from ministries of health and prominent healthcare leaders.
に公開 2021年 7月 1日
The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) will bring together more than 14,000 attendees from all over the world, plus experts from relevant fields to present the latest findings and share their expertise.
に公開 2021年 8月 24日
The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only.
に公開 2021年 12月 20日
In this Q&A article, we look at some key questions healthcare professionals may have about point-of-care testing (POCT). We cover how POCT can be of value within specific clinical fields and in clinicians’ day-to-day roles, including discussion of how POCT may contribute to faster results, greater flexibility for patients and reduced antibiotic prescribing.
2021/11/25 13:00:00 木 25 11月 2021
2021/11/25 14:30:00 木 25 11月 2021
に公開 2021年 10月 21日
起こった 2021年 11月 25日
Join this interactive discussion on how the different adoption of C-reactive protein point-of-care testing in different countries has influenced and could influence antibiotic misuse and antimicrobial resistance rates.
に公開 2021年 10月 11日
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.In this article, we cover the below publication by Professor Cooke and co-authors
に公開 2022年 2月 4日
The guideline focusses on how clinicians can get the most efficacy and highest quality results from implementing best practices for POCT. The authors state that a quality assurance program is vital to managing reliability of POCT results.
This clinical practice guideline from the American College of cardiology (ACC) and American Heart Association (AHA) provides recommendations applicable to patients with or at risk of developing cardiovascular disease (CVD).
Dr. Erna Lenters-Westra, from the Department of Clinical Chemistry, Isala, Zwolle, The Nederlands, talks about HbA1c point-of-care testing, its advantages and perfomance-wise perspective.
に公開 2021年 9月 14日
Dr. MD. Verena Gantner, General Practitioner in Switzerland, talks about "CRP point-of-care testing for reducing antimicrobial resistance".
2022/03/09 15:00:00 水 09 3月 2022
2022/03/09 17:00:00 水 09 3月 2022
に公開 2022年 2月 7日
起こった 2022年 3月 9日
One-size does not fit all across today's diverse and dynamic test settings. From antigen to molecular tests and various use cases, rapid test methods offer unique and overlapping utility, advantages, and disadvantages.
2022/03/11 15:00:00 金 11 3月 2022
起こった 2022年 3月 11日
As variants evolve, vaccination gaps persist, and mask measures relax, diagnostic testing remains a cornerstone in the global fight against COVID-19.
2022/03/07 15:00:00 月 07 3月 2022
2022/03/07 16:00:00 月 07 3月 2022
起こった 2022年 3月 7日
On the threshold of the 2021-2022 respiratory season, this timely update centers on influenza A&B, the COVID-19 pandemic and steps healthcare systems are taking to prepare for the upcoming (and uncertain) respiratory season
Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.
This updated guidance from the Infectious Diseases Society of America (IDSA) aims to provide an evidence-based diagnostic guideline to assist clinicians, clinical laboratorians, patients and policymakers in decisions related to the optimal use of COVID-19 molecular diagnostic testing.
The objective of these guidelines from the World Health Organization (WHO) is to provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings.
The International Diabetes Federation (IDF) published an updated version of its flagship ‘Diabetes Atlas’ in 2019. The atlas covers evidence on the impact of diabetes worldwide, including recommendations for testing and screening.
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease (CKD) represents an update to the 2012 KDIGO guideline.
This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.
2022/04/26 15:00:00 火 26 4月 2022
に公開 2022年 4月 26日
起こった 2022年 4月 26日
The implementation of LF-LAM in patients with advanced HIV disease has showed promise as a simple, inexpensive POC platform. The webinar serves to provide insight into practical implementation of LF-LAM and demonstrate the successful integration in the South African context.
2022/05/03 15:00:00 火 03 5月 2022
2022/05/03 16:00:00 火 03 5月 2022
に公開 2022年 5月 3日
起こった 2022年 5月 3日
Omicron globally became the predominant SARS-CoV-2 variant in late 2021. Some studies have suggested Omicron has a different replication pattern that could affect detection by rapid antigen tests. Reports in social media have promulgated oral swabs as a superior sample for detecting Omicron in the early stage of infection compared to nasal swabs.
Faster and more effectivetechnology advances diagnostic testing within the walls of the central lab and indecentralized, near-patient settings. Explore the future of the lab and gain experts’insights on the broadened scope of the lab with test methods that provide qualityinformation supporting clinical needs and decision making.
2022/07/04 13:00:00 月 04 7月 2022
2022/07/04 14:00:00 月 04 7月 2022
起こった 2022年 7月 4日
Join this global webinar focused on Group A Strep (GAS) pharyngitis diagnostics and patient care.
The webinar was an opportunity to share the success of HIV POC EID & VL monitoring in Mozambique and Cameroon to a larger audience and allow key stakeholders to be informed on the benefits of m-PIMA as a critical tool in reaching HIV targets.
2022/09/28 14:00:00 水 28 9月 2022
2022/09/28 15:30:00 水 28 9月 2022
起こった 2022年 9月 28日
This webinar will discuss screening for and prevention of chronic disease in severe mental illness (SMI) patients and patients with learning disabilities (LD).
に公開 2022年 8月 22日
Sean D Currin, Mwawi S Gondwe, Nokthula B Mayindi, Shingirai Chipungu, Bongekile L Khoza, Stephen Tollman, June Fabian, Jaya A George, ARK Consortium
に公開 2022年 7月 26日
Albuminuria, commonly measured as urine albumin-to-creatinine ratio (ACR), is an under-recognized component of chronic kidney disease (CKD) definition, staging and prognosis.
0
接続されていません